Cellebrite DI stock: growth
CLBTCellebrite DI reported $475.68M in revenue for fiscal 2025, up 18.6% on the prior year, up 19.5% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2019 | |
|---|---|---|
| Revenue | 19.5% | 18.5% |
| Revenue per share | 12.8% | 12.9% |
| Earnings | 68.4% | no data |
| Earnings per share | no data | no data |
| Free cash flow | 20.9% | 58.2% |
| Free cash flow per share | 14.1% | 50.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2019 | $171.85M | −$1.88M | $9.92M |
| 2020 | $194.91M | $5.78M | $60.33M |
| 2021 | $246.25M | $71.4M | $27.94M |
| 2022 | $270.65M | $120.81M | $11.49M |
| 2023 | $325.11M | −$81.1M | $94.14M |
| 2024 | $401.2M | −$283.01M | $121.56M |
| 2025 | $475.68M | $78.33M | $155.73M |
Revenue by segment
How Cellebrite DI Ltd. makes its money and how that has shifted. Names are as the company reports them.
- Subscription Services70%
- Term-Licenses20%
- Professional Services6%
- Other4%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies.
Figures as a table
| 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|
| Subscription Services | $209.75M | $271.03M | $330.77M | 69.5% |
| Term-Licenses | $70.66M | $82.01M | $96.25M | 20.2% |
| Professional Services | $31.14M | $30.88M | $30.89M | 6.5% |
| Other | $13.56M | $17.29M | $17.77M | 3.7% |
| Total revenue | $325.11M | $401.2M | $475.68M | 100% |
Revenue by region
Where Cellebrite DI Ltd. generates its revenue.
- Americas54%
- EMEA34%
- Asia Pacific12%
Figures as a table
| 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|
| Americas | $126.93M | $141.92M | $172.15M | $215.53M | $256.58M | 53.9% |
| EMEA | $88.44M | $92.75M | $112.25M | $134.92M | $161.36M | 33.9% |
| Asia Pacific | $30.88M | $35.98M | $40.71M | $50.75M | $57.73M | 12.1% |
| Total revenue | $246.25M | $270.65M | $325.11M | $401.2M | $475.68M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 14 Nov 2025)
- Valuation signal Fairly valued since 13 Nov 2026, previously Overvalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
